Top brokers upgrade these 2 ASX large-cap market darlings to "buy"

Our market has defied expectations of a weaker opening this morning with a number of popular large-cap stocks bouncing back from the recent S&P/ASX 200 (Index:^AXJO) (ASX: XJO) sell-off .

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Our market has defied expectations of a weaker opening this morning with a number of popular large-cap stocks bouncing back from the recent sell-off that sent the S&P/ASX 200 (Index:^AXJO) (ASX: XJO) index dropping into "correction" territory.

But the top 200 stock index is fighting back with a 0.8% gain at the time of writing with the CSL Limited (ASX: CSL) share price, Altium Limited (ASX: ALU) share price and A2 Milk Company Ltd (ASX: A2M) share price outperforming the market.

It's not only these market darlings that have been a hot favourite of investors over the past year or two that are finding favour today.

Sleep disorder treatment company ResMed (RESMED/IDR UNRESTR (ASX: RMD)) is among the top five best performers on the ASX 200.

The ResMed share price rallied 2.6% gain to $14.63 and that's probably thanks to a recommendation upgrade by Credit Suisse to "outperform" from "neutral" following the company's quarterly result announcement last week (click here to read my take on the result).

ResMed is taking market share for both masks and devices in the US with earnings before interest and tax (EBIT) jumping 13% above Credit Suisse's forecast to 28% compared to a year ago while devices sales to the rest of the world jumped 20%.

"Both RMD and its competitor reported double-digit growth in US masks in 1Q19, suggesting the market is growing ahead of historical rates (high single-digits), with a further acceleration in re-supply," said the broker who has pegged a $15.10 price target on the stock.

"While we remain cautious of competitors taking share with new product launches, RMD's recently launched F30 minimal contact full-face mask should limit share shift in future quarters."

Another market darling that has fallen out of favour with investors recently is Carsales.Com Ltd (ASX: CAR) and commentary at its annual general meeting last week isn't helping with management changing its outlook for its core domestic business to "moderate" instead of "solid".

The online automotive classifieds business blamed weakness in display advertising and its financial services business Stratton for the downbeat assessment.

However, the 20% retreat in the Carsales.com share price over the past nine months has pushed the stock into the "buy" zone, according to Macquarie Group Ltd (ASX: MQG), which has upgraded its rating on the stock to "outperform" from "neutral".

"Against that backdrop and cognisant of the nearer-term macro concerns, we have upgraded to Outperform," said Macquarie.

"As discussed in previous research, we see broad-based earnings drivers for the business—including increased take-up of Premium/Promote products to drive the Core; as well as from International assets. The implied 1-year forward earnings multiple of 21.2x is an improved entry point for investors, vs 25.8x when we downgraded in February on valuation grounds."

Motley Fool contributor Brendon Lau owns shares of Macquarie Group Limited. The Motley Fool Australia owns shares of A2 Milk and Altium. The Motley Fool Australia has recommended carsales.com Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Five young people sit in a row having fun and interacting with their mobile phones.
Share Market News

5 ASX 200 growth shares to buy in December

Analysts think these shares could be great options for growth investors next month.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Share Market News

5 things to watch on the ASX 200 on Friday

How will the Australian market finish the week? Let's find out.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 notched up another record high this Thursday.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Record Highs

Wait, did the ASX 200 just hit another all-time high?!

It was another big day for the ASX 200 record books this Thursday.

Read more »

Three shareholders climbing ladders up into the clouds
Share Gainers

11 ASX All Ords shares rising faster than Nvidia over the past year

Who knew? Here are the homegrown ASX companies outperforming Nvidia on share price growth over the past 12 months.

Read more »

a man wearing a gold shirt smiles widely as he is engulfed in a shower of gold confetti falling from the sky. representing a new gold discovery by ASX mining share OzAurum Resources
Share Market News

Guess which ASX mining share is jumping 8% on 'exciting gold discovery'

It has been a golden day for owners of this mining share. Let's find out why.

Read more »

Buy and sell keys on an Apple keyboard.
Broker Notes

1 ASX 200 share to buy and 1 to sell now

Goldman Sachs has given its verdict on these two stocks.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Fisher & Paykel Healthcare, Humm, Novonix, and Webjet shares are tumbling today

These shares are having a tough session on Thursday. What's going on? Let's find out.

Read more »